Brought to you by 
Kallyope raises $44mm in Series A round
14 Dec 2015
Executive Summary
Newly launched New York biotech Kallyope Inc. (focused on gut-brain axis circuits) raised $44mm in a Series A round from eight investors including Lux Capital, Polaris Partners, The Column Group, Illumina Inc., Alexandria Venture Investments, and Tony Evnin, PhD, a partner at Venrock and a board member.
Deal Industry
- Pharmaceuticals
-
Medical Devices
- Diagnostic Imaging Equipment & Supplies
-
Biotechnology
-
Drug Discovery Tools
- Bioinformatics
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Kallyope raises $44mm in Series A round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice